Pfizer plays hardball in weight-loss drug fight
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Pfizer plays hardball in weight-loss drug fight
-
ナレーター：
-
著者：
このコンテンツについて
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing for wider global dollar adoption.
Mentioned in this podcast:
Palantir lifts 2025 sales outlook after posting strong quarterly growth
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid
OpenAI strikes $38bn computing deal with Amazon
US pushes for wider global dollar adoption
Today’s FT News Briefing was produced by Sonja Hutson, and Marc Filippino. Our show was mixed by Kelly Garry. Additional help from Michela Tindera, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.
Hosted on Acast. See acast.com/privacy for more information.